Subacute Sclerosing Panencephalitis in Children: The Archetype of Non-Vaccination

Laura Papetti1, Maria Elisa Amodeo2,3, Letizia Sabatini2,3

  • 1Neurology Unit, Department of Neuroscience, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy.

Viruses
|April 23, 2022
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) is a rare but severe measles complication. Vaccination remains the only effective prevention against this debilitating neurological disease.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Pediatrics

Background:

  • Subacute sclerosing panencephalitis (SSPE) is a fatal neurological sequela of measles virus infection.
  • SSPE incidence is rising due to decreased measles vaccination rates, exacerbated by the COVID-19 pandemic.

Observation:

  • SSPE presents as a late complication in previously healthy children post-measles infection.
  • The disease carries a high mortality and disability rate, with no specific cure.

Findings:

  • Current evidence and clinical experience confirm measles vaccination as the sole protective measure against SSPE.
  • Reduced vaccination adherence directly correlates with increased SSPE cases.

Implications:

  • Strengthening measles vaccination programs is crucial to prevent SSPE resurgence.
  • Public health initiatives must address vaccine hesitancy to protect children from SSPE.